This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovative Mind of Toshiro Ochiai
Introduction
Toshiro Ochiai is a notable inventor from Sunto-gun, Japan, recognized for his contributions to pharmaceuticals through innovative developments in microcrystal technology. He holds a patent that exemplifies his expertise in enhancing drug formulation, ultimately aiming to improve therapeutic outcomes.
Latest Patents
Ochiai's singular patent describes the creation of microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione. These microcrystals exhibit an average particle size of less than 50 micrometers and boast a crystallinity of 20% or more. His invention delivers excellent solubility, stability, bioavailability, and dispersing properties, making it a valuable addition to pharmaceutical formulations. The patent highlights the potential of these microcrystals to elevate the effectiveness of drug delivery systems.
Career Highlights
Toshiro Ochiai has made significant strides in the pharmaceutical industry, particularly through his role at Kyowa Hakko Kirin Co., Limited. His work has focused on advancements in drug formulation and development, contributing to the evolving landscape of pharmaceuticals. His patent reflects not just innovative thought but also a deep understanding of the challenges besetting drug solubility and bioavailability.
Collaborations
Throughout his career, Ochiai has collaborated with fellow researchers, including Kazutoshi Kuroda and Noboru Aoki. These collaborations have likely enriched his research endeavors, fostering a collective approach to innovation in pharmaceutical sciences. Working together with skilled professionals in the field has enabled the advancement and practical application of their collective findings.
Conclusion
Toshiro Ochiai's contributions to the world of pharmaceuticals through his innovative patent on microcrystal technology underscore his role as a leading inventor. His work at Kyowa Hakko Kirin Co., Limited, coupled with fruitful collaborations, showcases a commitment to enhancing drug efficacy and accessibility. As the pharmaceutical landscape continues to evolve, inventors like Ochiai play a pivotal role in pushing the boundaries of innovation for improved health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
